<?xml version="1.0" encoding="UTF-8"?>
<ref id="B47-pharmaceutics-10-00039">
 <label>47.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ramanathan</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Abel</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Tweedy</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>West</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Hui</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Kearney</surname>
    <given-names>B.P.</given-names>
   </name>
  </person-group>
  <article-title>Pharmacokinetic interaction of ritonavir-boosted elvitegravir and maraviroc</article-title>
  <source>J. Acquir. Immune Defic. Syndr.</source>
  <year>2010</year>
  <volume>53</volume>
  <fpage>209</fpage>
  <lpage>214</lpage>
  <pub-id pub-id-type="doi">10.1097/QAI.0b013e3181ba4536</pub-id>
  <?supplied-pmid 19851115?>
  <pub-id pub-id-type="pmid">19851115</pub-id>
 </element-citation>
</ref>
